Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ingrid Banovic"'
Publikováno v:
Psychology, Health & Medicine
Psychology, Health & Medicine, 2010, 15 (4), pp.394-405. 〈10.1080/13548501003759155〉
Psychology Health & Medicine
Psychology Health & Medicine, 2010, pp.525
Psychology, Health and Medicine
Psychology, Health and Medicine, 2010, 15 (4), pp.394-405. ⟨10.1080/13548501003759155⟩
Psychology, Health and Medicine, Taylor & Francis (Routledge), 2010, 15 (4), pp.394-405. ⟨10.1080/13548501003759155⟩
Psychology, Health and Medicine, Taylor & Francis (Routledge), 2010, 15 (4), pp.394-405
Psychology, Health and Medicine, Taylor & Francis (Routledge), 2010, pp.525
Psychology, Health & Medicine, 2010, 15 (4), pp.394-405. 〈10.1080/13548501003759155〉
Psychology Health & Medicine
Psychology Health & Medicine, 2010, pp.525
Psychology, Health and Medicine
Psychology, Health and Medicine, 2010, 15 (4), pp.394-405. ⟨10.1080/13548501003759155⟩
Psychology, Health and Medicine, Taylor & Francis (Routledge), 2010, 15 (4), pp.394-405. ⟨10.1080/13548501003759155⟩
Psychology, Health and Medicine, Taylor & Francis (Routledge), 2010, 15 (4), pp.394-405
Psychology, Health and Medicine, Taylor & Francis (Routledge), 2010, pp.525
International audience; Fatigue in Crohn's disease (CD) is considered as a consequence of the disease and its treatment. If research showed the impact of the activity of the disease on vitality, patients can express fatigue even if the disease is ina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba456a67a42401892815d25d56e00467
https://hal.archives-ouvertes.fr/hal-00579314
https://hal.archives-ouvertes.fr/hal-00579314
Publikováno v:
Traffic
Traffic, Wiley, 2009, 3 ((1)), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2008, pp.Ms. Ref. No. CROHNS-D-08-00028R1. 〈10.1016/j.crohns.2008.10.003〉
Traffic, 2009, 3 ((1)), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2008, pp.Ms. Ref. No. CROHNS-D-08-00028R1. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2009, 3 (1), pp.25-31
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2009, 3 (1), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
Traffic, Wiley, 2009, 3 ((1)), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2008, pp.Ms. Ref. No. CROHNS-D-08-00028R1. 〈10.1016/j.crohns.2008.10.003〉
Traffic, 2009, 3 ((1)), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2008, pp.Ms. Ref. No. CROHNS-D-08-00028R1. ⟨10.1016/j.crohns.2008.10.003⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2009, 3 (1), pp.25-31
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2009, 3 (1), pp.25-31. ⟨10.1016/j.crohns.2008.10.003⟩
International audience; UNLABELLED: BACKGROUND AND AIMS AND METHOD: Although Infliximab is a very potent therapy of refractory Crohn's disease, its administration requires iterative infusions in hospital and there are concerns regarding its long-term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a7e20f8ce1a5f47937e8cb797c2347
https://hal.archives-ouvertes.fr/hal-00944395
https://hal.archives-ouvertes.fr/hal-00944395